Hepatocyte growth factor activator (HGFA): Pathophysiological functions in vivo

FEBS Journal

Volumn 277, Issue 10, 2010, Pages 2230-2237

  Kataoka, Hiroaki ^a   Kawaguchi, Makiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Hepatocyte growth factor; Hepatocyte growth factor activator; HGF activator; Macrophage stimulating protein; Tissue injury

Indexed keywords

ENZYME PRECURSOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR; MACROPHAGE STIMULATING PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SERINE PROTEINASE; UNCLASSIFIED DRUG;

CELL ACTIVITY; CELL SURVIVAL; CIRCULATION; ENZYME ACTIVATION; ENZYME RELEASE; ENZYME SUBSTRATE; ENZYME SYNTHESIS; EPITHELIUM CELL; HUMAN; IN VIVO STUDY; INFLAMMATION; LIVER; LUNG FIBROSIS; MACROPHAGE; MORPHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; STROMA CELL; TISSUE INJURY; TISSUE REGENERATION; TUMOR CELL; TUMOR GROWTH; WOUND HEALING;

ANIMALS; HEPATOCYTE GROWTH FACTOR; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; REGENERATION; SERINE ENDOPEPTIDASES;

MUS;

EID: 77951719025     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07640.x     Document Type: Short Survey

References (46)

1. Matsumoto K Nakamura T (2006) Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119, 477 483.
2. Kataoka H, Miyata S, Uchinokura S Itoh H (2003) Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev 22, 223 236.
3. Szabo R Bugge TH (2008) Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 40, 1297 1316.
4. Shimomura T, Ochiai M, Kondo J Morimoto Y (1992) A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8, 219 229.
5. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y Kitamura N (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268, 10024 10028.
6. Kitajima Y, Ide T, Ohtsuka T Miyazaki K (2008) Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 99, 1341 1347.
7. Itoh H, Hamasuna R, Kataoka H, Yamauchi M, Miyazawa K, Kitamura N Koono M (2000) Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract. Biochim Biophys Acta 1491, 295 302.
8. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, Miyazawa K Koono M (2000) Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 275, 40453 40462.
9. Eigenbrot C, Ganesan R Kirchhofer D (2010) Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HAI-1. FEBS J 277, 2215 2222.
10. Suzuki K (2010) Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor. FEBS J 277, 2223 2229.
11. Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y Kitamura N (1993) Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 268, 22927 22932.
12. Nagakawa O, Yamagishi T, Fujiuchi Y, Junicho A, Akashi T, Nagaike K Fuse H (2005) Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer. Eur Urol 48, 686 690. (Pubitemid 41278597)
13. Wader KF, Fagerli UM, Holt RU, Stordal B, Borset M, Sundan A Waage A (2008) Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma. Eur J Haematol 81, 380 383.
14. van Adelsberg J, Sehgal S, Kukes A, Brady C, Barasch J, Yang J Huan Y (2001) Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro. J Biol Chem 276, 15099 15106.
15. Hayashi T, Abe K, Sakurai M Itoyama Y (1998) Induction of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res 799, 311 316. (Pubitemid 28351263)
16. Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G Yoshino S (2001) Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol 28, 1772 1778.
17. Lee YR, Yamazaki M, Mitsui S, Tsuboi R Ogawa H (2001) Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation. J Dermatol Sci 25, 156 163.
18. Moriyama T, Kataoka H, Tsubouchi H Koono M (1995) Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372, 78 82.
19. Kataoka H, Hamasuna R, Itoh H, Kitamura N Koono M (2000) Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res 60, 6148 6159.
20. Tjin EP, Derksen PW, Kataoka H, Spaargaren M Pals ST (2004) Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood 104, 2172 2175.
21. Tjin EP, Groen RW, Vogelzang I, Derksen PW, Klok MD, Meijer HP, van Eeden S, Pals ST Spaargaren M (2006) Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma. Blood 107, 760 768.
22. Su W, Gutmann DH, Perry A, Abounader R, Laterra J Sherman LS (2004) CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Glia 45, 297 306.
23. Parr C Jiang WG (2001) Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 19, 857 863.
24. Miyazawa K, Shimomura T Kitamura N (1996) Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271, 3615 3618.
25. Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y Kataoka H (2008) Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. FEBS J 275, 1003 1017.
26. Kawaguchi M, Orikawa H, Baba T, Fukushima T Kataoka H (2009) Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J 276, 3481 3490.
27. Wang MH, Zhou YQ Chen YQ (2002) Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol 56, 545 553.
28. Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K, Kimura S, Omata M, Shiokawa K, Kitamura N et al. (1998) Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract. Biochem Biophys Res Commun 253, 477 484.
29. Tjin EP, Bende RJ, Derksen PW, van Huijstee AP, Kataoka H, Spaargaren M Pals ST (2005) Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator. J Immunol 175, 2807 2813.
30. Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T et al. (2004) Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127, 1423 1435.
31. Miyazawa K (2010) Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J 277, 2208 2214.
32. Tang W, Miyazawa K Kitamura N (1995) Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy or unilateral nephrectomy. FEBS Lett 362, 220 224.
33. Kaibori M, Inoue T, Oda M, Naka D, Kawaguchi T, Kitamura N, Miyazawa K, Kwon AH, Kamiyama Y Okumura T (2002) Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF. Biochem Biophys Res Commun 290, 475 481.
34. Nagai M, Takahashi N, Miyazawa K, Kawaguchi M, Chijiiwa K Kataoka H (2008) Activation of MET receptor tyrosine kinase in ulcer surface epithelial cells undergoing restitution. Pathol Int 58, 462 464.
35. Marchand-Adam S, Fabre A, Mailleux AA, Marchal J, Quesnel C, Kataoka H, Aubier M, Dehoux M, Soler P Crestani B (2006) Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174, 58 66.
36. Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H, Soler P Crestani B (2010) Imbalance in the pro-HGF activation system in bleomycin-induced lung fibrosis in mice. Am J Respir Cell Mol Biol, 42, 288 293.
37. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG et al. (1996) Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74, 1862 1868.
38. Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S Kataoka H (2006) Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int J Cancer 118, 583 592.
39. Parr C Jiang WG (2006) Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 119, 1176 1183.
40. Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B et al. (2005) Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 65, 4598 4606.
41. Nakamura K, Abarzua F, Hongo A, Kodama J, Nasu Y, Kumon H Hiramatsu Y (2009) Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. Ann Oncol 20, 63 70.
42. Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S Koono M (2001) Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int J Cancer 93, 339 345.
43. Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE, Smith CA, Taylor MD Rutka JT (2008) An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 68, 9945 9953.
44. Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H Saisho H (2003) Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Cancer Res 63, 8674 8679.
45. Yasuda K, Nagakawa O, Akashi T, Fujiuchi Y, Koizumi K, Komiya A, Saiki I Fuse H (2009) Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate 69, 346 351.
46. Parr C, Watkins G, Mansel RE Jiang WG (2004) The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 10, 202 211. (Pubitemid 38114181)